angiotensin-converting enzyme 2

  • Dietmar SchomburgEmail author
  • Ida Schomburg
Part of the Springer Handbook of Enzymes book series (HDBKENZYMES, volume 10)


EC number

Recommended name

 angiotensin-converting enzyme 2


 ACE <4> [12]

 ACE 2 <10,12,13> [74]

 ACE-2 <2,3,4,9> [38,68]

 ACE-related carboxypeptidase <9> [3]

 ACE2 <1,2,3,4,5,6,9,10,11,12,13> [1,2,3,5,6,9,14,15,16,17,19,20,22,25,26,30,37,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,65,66,67,68,69,70,71,72,73,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,96,97]

 ACE2 homologue <2> [41]

 ACEH <9> [7]

 Ang converting enzyme 2 <10,12,13> [74]

 angiotensin II converting enzyme 2 <3> [81]

 angiotensin converting enzyme 2 <2,3,4,6,9,10,11,12,13> (<3> functions as a carboxypeptidase [41]) [14,41,43,46,47,51,55,57,58,60,63,74,78,84]

 angiotensin converting enzyme II <9> [95]

 angiotensin converting enzyme-2 <2,3,4> [38]

 angiotensin-converting enzyme <4,9> [22]

 angiotensin-converting enzyme 2 <4,8,9,10,12,13> [10,19,67,68,70,76]

 angiotensin-converting enzyme homolog <9> [7]

 angiotensin-converting enzyme homologue <9> [6]

 angiotensin-converting enzyme type 2 <13> [79]

 angiotensin-converting enzyme-2 <3,4> [37,53,97]

 angiotensin-converting enzyme-like protein <9> [7]

 angiotensin-converting enzyme-related carboxypeptidase <9> [1,6]

 angiotensinase <9> [4]

 hACE2 <3,10,13> [36,67,74]

CAS registry number



Pulmonary Arterial Hypertension Severe Acute Respiratory Syndrome Severe Acute Respiratory Syndrome Severe Acute Respiratory Syndrome Coronavirus Severe Acute Respiratory Syndrome Coronavirus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Yan, Z.H.; Ren, K.J.; Wang, Y.; Chen, S.; Brock, T.A.; Rege, A.A.: Development of intramolecularly quenched fluorescent peptides as substrates of angiotensin-converting enzyme 2. Anal. Biochem., 312, 141-147 (2003)CrossRefPubMedGoogle Scholar
  2. 2.
    Guy, J.L.; Jackson, R.M.; Acharya, K.R.; Sturrock, E.D.; Hooper, N.M.; Turner, A.J.: Angiotensin-converting enzyme-2 (ACE2): comparative modeling of the active site, specificity requirements, and chloride dependence. Biochemistry, 42, 13185-13192 (2003)CrossRefPubMedGoogle Scholar
  3. 3.
    Donoghue, M.; Hsieh, F.; Baronas, E.; Godbout, K.; Gosselin, M.; Stagliano, N.; Donovan, M.; Woolf, B.; Robison, K.; Jeyaseelan, R.; Breitbart, R.E.; Acton, S.: A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ. Res., 87, E1-9 (2000)CrossRefPubMedGoogle Scholar
  4. 4.
    Zisman, L.S.; Keller, R.S.; Weaver, B.; Lin, Q.; Speth, R.; Bristow, M.R.; Canver, C.C.: Increased angiotensin-(1-7)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme homologue ACE2. Circulation, 108, 1707-1712 (2003)CrossRefPubMedGoogle Scholar
  5. 5.
    Tikellis, C.; Johnston, C.I.; Forbes, J.M.; Burns, W.C.; Burrell, L.M.; Risvanis, J.; Cooper, M.E.: Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy. Hypertension, 41, 392-397 (2003)CrossRefPubMedGoogle Scholar
  6. 6.
    Dales, N.A.; Gould, A.E.; Brown, J.A.; Calderwood, E.F.; Guan, B.; Minor, C.A.; Gavin, J.M.; Hales, P.; Kaushik, V.K.; Stewart, M.; Tummino, P.J.; Vickers, C.S.; Ocain, T.D.; Patane, M.A.: Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors. J. Am. Chem. Soc., 124, 11852-11853 (2002)CrossRefPubMedGoogle Scholar
  7. 7.
    Tipnis, S.R.; Hooper, N.M.; Hyde, R.J.; Christie, G.; Karran, E.; Turner, A.J.: A humen homolog of angiotensin converting enzyme - cloning and functional expression as a captopril-insensitive carboxypeptidase. J. Biol. Chem., 275, 33238-33243 (2000)CrossRefPubMedGoogle Scholar
  8. 8.
    Vickers, C.; Hales, P.; Kaushik, V.; Dick, L.; Gavin, J.; Tang, J.; Godbout, K.; Parsons, T.; Baronas, E.; Hsieh, F.; Acton, S.; Patane, M.; Nichols, A.; Tummino, P.: Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J. Biol. Chem., 277, 14838-14843 (2002)CrossRefPubMedGoogle Scholar
  9. 9.
    Huang, L.; Sexton, D.J.; Skogerson, K.; Devlin, M.; Smith, R.; Sanyal, I.; Parry, T.; Kent, R.; Enright, J.; Wu, Q.L.; Conley, G.; DeOliveira, D.; Morganelli, L.; Ducar, M.; Wescott, C.R.; Ladner, R.C.: Novel peptide inhibitors of angiotensin-converting enzyme 2. J. Biol. Chem., 278, 15532-15540 (2003)CrossRefPubMedGoogle Scholar
  10. 10.
    Stoesser, G.; Baker, W.; van den Broek, A.; Garcia-Pastor, M.; Kanz, C.; Kulikova, T.; Leinonen, R.; Lin Q.; Lombard, V.; Lopez, R.; Mancuso, R.; Nardone, F.; Stoehr, P.; Tuli, M.A.; Tzouvara, K.; Vaughan, R.: The EMBL Nucleotide Sequence Database: major new developments. Nucleic Acids Res., 31, 17-22 (2003)CrossRefPubMedGoogle Scholar
  11. 11.
    Benson, D.A.; Karsch-Mizrachi, I.; Lipman, D.J.; Ostell, J.; Wheeler, D.L.: GenBank: update. Nucleic Acids Res., 32, D23-D26 (2004)CrossRefGoogle Scholar
  12. 12.
    Dantas, A.P.; Sandberg, K.: Regulation of ACE2 and ANG-(1-7) in the aorta: New insights into the renin-angiotensin system in the control of vascular function. Am. J. Physiol., 289, H980-H981 (2005)Google Scholar
  13. 13.
    Gallagher, P.E.; Chappell, M.C.; Ferrario, C.M.; Tallant, E.A.: Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes. Am. J. Physiol., 290, C420-C426 (2006)CrossRefGoogle Scholar
  14. 14.
    Li, N.; Zimpelmann, J.; Cheng, K.; Wilkins, J.A.; Burns, K.D.: The role of angiotensin converting enzyme 2 in the generation of angiotensin 1-7 by rat proximal tubules. Am. J. Physiol. Renal Physiol., 288, F353-F362 (2005)CrossRefPubMedGoogle Scholar
  15. 15.
    Rice, G.I.; Thomas, D.A.; Grant, P.J.; Turner, A.J.; Hooper, N.M.: Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem. J., 383, 45-51 (2004)CrossRefPubMedGoogle Scholar
  16. 16.
    Warner, F.J.; Smith, A.I.; Hooper, N.M.; Turner, A.J.: Angiotensin-converting enzyme-2: a molecular and cellular perspective. Cell. Mol. Life Sci., 61, 2704-2713 (2004)CrossRefPubMedGoogle Scholar
  17. 17.
    Danilczyk, U.; Eriksson, U.; Oudit, G.Y.; Penninger, J.M.: Physiological roles of angiotensin-converting enzyme 2. Cell. Mol. Life Sci., 61, 2714-2719 (2004)CrossRefPubMedGoogle Scholar
  18. 18.
    Kuhn, J.H.; Li, W.; Choe, H.; Farzan, M.: Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus. Cell. Mol. Life Sci., 61, 2738-2743 (2004)CrossRefPubMedGoogle Scholar
  19. 19.
    Ferrario, C.M.; Jessup, J.; Chappell, M.C.; Averill, D.B.; Brosnihan, K.B.; Tallant, E.A.; Diz, D.I.; Gallagher, P.E.: Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation, 111, 2605-2610 (2005)CrossRefPubMedGoogle Scholar
  20. 20.
    Tikellis, C.; Johnston, C.I.; Forbes, J.M.; Burns, W.C.; Thomas, M.C.; Lew, R.A.; Yarski, M.; Smith, A.I.; Cooper, M.E.: Identification of angiotensin converting enzyme 2 in the rodent retina. Curr. Eye Res., 29, 419-427 (2004)CrossRefPubMedGoogle Scholar
  21. 21.
    Kuba, K.; Imai, Y.; Penninger, J.M.: Angiotensin-converting enzyme 2 in lung diseases. Curr. Opin. Pharmacol., 6, 271-276 (2006)CrossRefPubMedGoogle Scholar
  22. 22.
    Douglas, G.C.; OBryan, M.K.; Hedger, M.P.; Lee, D.K.; Yarski, M.A.; Smith, A.I.; Lew, R.A.: The novel angiotensin-converting enzyme (ACE) homolog, ACE2, is selectively expressed by adult Leydig cells of the testis. Endocrinology, 145, 4703-4711 (2004)CrossRefPubMedGoogle Scholar
  23. 23.
    Katovich, M.J.; Grobe, J.L.; Huentelman, M.; Raizada, M.K.: Angiotensinconverting enzyme 2 as a novel target for gene therapy for hypertension. Exp. Physiol., 90, 299-305 (2005)CrossRefPubMedGoogle Scholar
  24. 24.
    Guy, J.L.; Jackson, R.M.; Jensen, H.A.; Hooper, N.M.; Turner, A.J.: Identification of critical active-site residues in angiotensin-converting enzyme-2 (ACE2) by site-directed mutagenesis. FEBS J., 272, 3512-3520 (2005)CrossRefPubMedGoogle Scholar
  25. 25.
    Riviere, G.; Michaud, A.; Breton, C.; VanCamp, G.; Laborie, C.; Enache, M.; Lesage, J.; Deloof, S.; Corvol, P.; Vieau, D.: Angiotensin-converting enzyme 2 (ACE2) and ACE activities display tissue-specific sensitivity to undernutrition-programmed hypertension in the adult rat. Hypertension, 46, 1169-1174 (2005)CrossRefPubMedGoogle Scholar
  26. 26.
    Elased, K.M.; Cunha, T.S.; Gurley, S.B.; Coffman, T.M.; Morris, M.: New mass spectrometric assay for angiotensin-converting enzyme 2 activity. Hypertension, 47, 1010-1017 (2006)CrossRefPubMedGoogle Scholar
  27. 27.
    Ferrario, C.M.: Angiotensin-converting enzyme 2 and angiotensin-(1-7): an evolving story in cardiovascular regulation. Hypertension, 47, 515-521 (2006)CrossRefPubMedGoogle Scholar
  28. 28.
    Rice, G.I.; Jones, A.L.; Grant, P.J.; Carter, A.M.; Turner, A.J.; Hooper, N.M.: Circulating activities of angiotensin-converting enzyme, its homolog, angiotensin-converting enzyme 2, and neprilysin in a family study. Hypertension, 48, 914-920 (2006)CrossRefPubMedGoogle Scholar
  29. 29.
    Lew, R.A.; Warner, F.J.; Hanchapola, I.; Smith, A.I.: Characterization of angiotensin converting enzyme-2 (ACE2) in human urine. Int. J. Pept. Res. Ther., 12, 283-289 (2006)CrossRefGoogle Scholar
  30. 30.
    Warner, F.J.; Lew, R.A.; Smith, A.I.; Lambert, D.W.; Hooper, N.M.; Turner, A.J.: Angiotensin-converting enzyme 2 (ACE2), but not ACE, is preferentially localized to the apical surface of polarized kidney cells. J. Biol. Chem., 280, 39353-39362 (2005)CrossRefPubMedGoogle Scholar
  31. 31.
    Campbell, D.J.; Zeitz, C.J.; Esler, M.D.; Horowitz, J.D.: Evidence against a major role for angiotensin converting enzyme-related carboxypeptidase (ACE2) in angiotensin peptide metabolism in the human coronary circulation. J. Hypertens., 22, 1971-1976 (2004)CrossRefPubMedGoogle Scholar
  32. 32.
    To, K.F.; Lo, A.W.: Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2 (ACE2). J. Pathol., 203, 740-743 (2004)CrossRefPubMedGoogle Scholar
  33. 33.
    Kuba, K.; Imai, Y.; Rao, S.; Gao, H.; Guo, F.; Guan, B.; Huan, Y.; Yang, P.; Zhang, Y.; Deng, W.; Bao, L.; Zhang, B.; Liu, G.; Wang, Z.; Chappell, M.; Liu, Y.; Zheng, D.; Leibbrandt, A.; Wada, T.; Slutsky, A.S.; Liu, D.; Qin, C.; Jiang, C.; Penninger, J.M.: A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat. Med., 11, 875-879 (2005)CrossRefPubMedGoogle Scholar
  34. 34.
    Imai, Y.; Kuba, K.; Rao, S.; Huan, Y.; Guo, F.; Guan, B.; Yang, P.; Sarao, R.; Wada, T.; Leong-Poi, H.; Crackower, M.A.; Fukamizu, A.; Hui, C.C.; Hein, L.; Uhlig, S.; Slutsky, A.S.; Jiang, C.; Penninger, J.M.: Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature, 436, 112-116 (2005)CrossRefPubMedGoogle Scholar
  35. 35.
    Valdes, G.; Neves, L.A.; Anton, L.; Corthorn, J.; Chacon, C.; Germain, A.M.; Merrill, D.C.; Ferrario, C.M.; Sarao, R.; Penninger, J.; Brosnihan, K.B.: Distribution of angiotensin-(1-7) and ACE2 in human placentas of normal and pathological pregnancies. Placenta, 27, 200-207 (2006)CrossRefPubMedGoogle Scholar
  36. 36.
    Huentelman, M.J.; Zubcevic, J.; Katovich, M.J.; Raizada, M.K.: Cloning and characterization of a secreted form of angiotensin-converting enzyme 2. Regul. Pept., 122, 61-67 (2004)CrossRefPubMedGoogle Scholar
  37. 37.
    Trask, A.J.; Averill, D.B.; Ganten, D.; Chappell, M.C.; Ferrario, C.M.: Primary role of angiotensin-converting enzyme-2 in cardiac production of angiotensin-(1-7) in transgenic Ren-2 hypertensive rats. Am. J. Physiol. Heart Circ. Physiol., 292, H3019-H3024 (2007)CrossRefPubMedGoogle Scholar
  38. 38.
    Li, X.; Molina-Molina, M.; Abdul-Hafez, A.; Uhal, V.; Xaubet, A.; Uhal, B.D.: Angiotensin converting enzyme-2 is protective but downregulated in human and experimental lung fibrosis. Am. J. Physiol. Lung Cell Mol. Physiol., 295, L178-185 (2008)CrossRefPubMedGoogle Scholar
  39. 39.
    Joyner, J.; Neves, L.A.; Granger, J.P.; Alexander, B.T.; Merrill, D.C.; Chappell, M.C.; Ferrario, C.M.; Davis, W.P.; Brosnihan, K.B.: Temporal-spatial expression of ANg-(1-7) and angiotensin-converting enzyme 2 in the kidney of normal and hypertensive pregnant rats. Am. J. Physiol. Regul. Integr. Comp. Physiol., 293, R169-R177 (2007)CrossRefPubMedGoogle Scholar
  40. 40.
    Ho, T.Y.; Wu, S.L.; Chen, J.C.; Li, C.C.; Hsiang, C.Y.: Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction. Antiviral Res., 74, 92-101 (2007)CrossRefPubMedGoogle Scholar
  41. 41.
    Lambert, D.W.; Hooper, N.M.; Turner, A.J.: Angiotensin-converting enzyme 2 and new insights into the renin-angiotensin system. Biochem. Pharmacol., 75, 781-786 (2008)CrossRefPubMedGoogle Scholar
  42. 42.
    Deaton, D.N.; Gao, E.N.; Graham, K.P.; Gross, J.W.; Miller, A.B.; Strelow, J.M.: Thiol-based angiotensin-converting enzyme 2 inhibitors: P1 modifications for the exploration of the S1 subsite. Bioorg. Med. Chem. Lett., 18, 732-737 (2008)CrossRefPubMedGoogle Scholar
  43. 43.
    Zhong, J.C.; Yu, X.Y.; Lin, Q.X.; Li, X.H.; Huang, X.Z.; Xiao, D.Z.; Lin, S.G.: Enhanced angiotensin converting enzyme 2 regulates the insulin/Akt signalling pathway by blockade of macrophage migration inhibitory factor expression. Br. J. Pharmacol., 153, 66-74 (2008)CrossRefPubMedGoogle Scholar
  44. 44.
    Keidar, S.; Kaplan, M.; Gamliel-Lazarovich, A.: ACE2 of the heart: From angiotensin I to angiotensin (1-7). Cardiovasc. Res., 73, 463-469 (2007)CrossRefPubMedGoogle Scholar
  45. 45.
    Imai, Y.; Kuba, K.; Penninger, J.M.: Angiotensin-converting enzyme 2 in acute respiratory distress syndrome. Cell. Mol. Life Sci., 64, 2006-2012 (2007)CrossRefPubMedGoogle Scholar
  46. 46.
    Koitka, A.; Cooper, M.E.; Thomas, M.C.; Tikellis, C.: Angiotensin converting enzyme 2 in the kidney. Clin. Exp. Pharmacol. Physiol., 35, 420-425 (2008)CrossRefPubMedGoogle Scholar
  47. 47.
    Imai, Y.; Kuba, K.; Penninger, J.M.: The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice. Exp. Physiol., 93, 543-548 (2008)CrossRefPubMedGoogle Scholar
  48. 48.
    Zulli, A.; Rai, S.; Buxton, B.F.; Burrell, L.M.; Hare, D.L.: Co-localization of angiotensin-converting enzyme 2-, octomer-4- and CD34-positive cells in rabbit atherosclerotic plaques. Exp. Physiol., 93, 564-569 (2008)CrossRefPubMedGoogle Scholar
  49. 49.
    Guy, J.L.; Lambert, D.W.; Turner, A.J.; Porter, K.E.: Functional angiotensinconverting enzyme 2 is expressed in human cardiac myofibroblasts. Exp. Physiol., 93, 579-588 (2008)CrossRefPubMedGoogle Scholar
  50. 50.
    Garabelli, P.J.; Modrall, J.G.; Penninger, J.M.; Ferrario, C.M.; Chappell, M.C.: Distinct roles for angiotensin-converting enzyme 2 and carboxypeptidase A in the processing of angiotensins within the murine heart. Exp. Physiol., 93, 613-621 (2008)CrossRefPubMedGoogle Scholar
  51. 51.
    Elased, K.M.; Cunha, T.S.; Marcondes, F.K.; Morris, M.: Brain angiotensinconverting enzymes: role of angiotensin-converting enzyme 2 in processing angiotensin II in mice. Exp. Physiol., 93, 665-675 (2008)CrossRefPubMedGoogle Scholar
  52. 52.
    Lew, R.A.; Warner, F.J.; Hanchapola, I.; Yarski, M.A.; Manohar, J.; Burrell, L.M.; Smith, A.I.: Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor. Exp. Physiol., 93, 685-693 (2008)CrossRefPubMedGoogle Scholar
  53. 53.
    Lambert, D.W.; Clarke, N.E.; Hooper, N.M.; Turner, A.J.: Calmodulin interacts with angiotensin-converting enzyme-2 (ACE2) and inhibits shedding of its ectodomain. FEBS Lett., 582, 385-390 (2008)CrossRefPubMedGoogle Scholar
  54. 54.
    Yamazato, M.; Yamazato, Y.; Sun, C.; Diez-Freire, C.; Raizada, M.K.: Overexpression of angiotensin-converting enzyme 2 in the rostral ventrolateral medulla causes long-term decrease in blood pressure in the spontaneously hypertensive rats. Hypertension, 49, 926-931 (2007)CrossRefPubMedGoogle Scholar
  55. 55.
    Der Sarkissian, S.; Grobe, J.L.; Yuan, L.; Narielwala, D.R.; Walter, G.A.; Katovich, M.J.; Raizada, M.K.: Cardiac overexpression of angiotensin converting enzyme 2 protects the heart from ischemia-induced pathophysiology. Hypertension, 51, 712-718 (2008)CrossRefGoogle Scholar
  56. 56.
    Ye, M.; Wysocki, J.; William, J.; Soler, M.J.; Cokic, I.; Batlle, D.: Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin-converting enzyme: implications for albuminuria in diabetes. J. Am. Soc. Nephrol., 17, 3067-3075 (2006)CrossRefPubMedGoogle Scholar
  57. 57.
    Wiener, R.S.; Cao, Y.X.; Hinds, A.; Ramirez, M.I.; Williams, M.C.: Angiotensin converting enzyme 2 is primarily epithelial and is developmentally regulated in the mouse lung. J. Cell. Biochem., 101, 1278-1291 (2007)CrossRefPubMedGoogle Scholar
  58. 58.
    Rella, M.; Rushworth, C.A.; Guy, J.L.; Turner, A.J.; Langer, T.; Jackson, R.M.: Structure-based pharmacophore design and virtual screening for novel angiotensin converting enzyme 2 inhibitors. J. Chem. Inf. Model., 46, 708-716 (2006)CrossRefPubMedGoogle Scholar
  59. 59.
    Herath, C.B.; Warner, F.J.; Lubel, J.S.; Dean, R.G.; Jia, Z.; Lew, R.A.; Smith, A.I.; Burrell, L.M.; Angus, P.W.: Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis. J. Hepatol., 47, 387-395 (2007)CrossRefPubMedGoogle Scholar
  60. 60.
    Zulli, A.; Burrell, L.M.; Widdop, R.E.; Black, M.J.; Buxton, B.F.; Hare, D.L.: Immunolocalization of ACE2 and AT2 receptors in rabbit atherosclerotic plaques. J. Histochem. Cytochem., 54, 147-150 (2006)CrossRefPubMedGoogle Scholar
  61. 61.
    Mores, A.; Matziari, M.; Beau, F.; Cuniasse, P.; Yiotakis, A.; Dive, V.: Development of potent and selective phosphinic peptide inhibitors of angiotensin-converting enzyme 2. J. Med. Chem., 51, 2216-2226 (2008)CrossRefPubMedGoogle Scholar
  62. 62.
    Fukushi, S.; Mizutani, T.; Sakai, K.; Saijo, M.; Taguchi, F.; Yokoyama, M.; Kurane, I.; Morikawa, S.: Amino acid substitutions in the s2 region enhance severe acute respiratory syndrome coronavirus infectivity in rat angiotensin-converting enzyme 2-expressing cells. J. Virol., 81, 10831-10834 (2007)CrossRefPubMedGoogle Scholar
  63. 63.
    Guo, H.; Guo, A.; Wang, C.; Yan, B.; Lu, H.; Chen, H.: Expression of feline angiotensin converting enzyme 2 and its interaction with SARS-CoV S1 protein. Res. Vet. Sci., 84, 494-496 (2008)CrossRefPubMedGoogle Scholar
  64. 64.
    Koka, V.; Huang, X.R.; Chung, A.C.; Wang, W.; Truong, L.D.; Lan, H.Y.: Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK/p38 MAP kinase pathway. Am. J. Pathol., 172, 1174-1183 (2008)CrossRefPubMedGoogle Scholar
  65. 65.
    Herath. C.B.; Lubel, J.S.; Jia, Z.; Velkoska, E.; Casley, D.; Brown, L.; Tikellis, C.; Burrell, L.M.; Angus, P.W.: Portal pressure responses and angiotensin peptide production in rat liver are determined by relative activity of angiotensin converting enzyme (ACE) and ACE2. Am. J. Physiol. Gastrointest. Liver Physiol., 297, G98-G106 (2009)CrossRefGoogle Scholar
  66. 66.
    Levy, A.; Yagil, Y.; Bursztyn, M.; Barkalifa, R.; Scharf, S.; Yagil, C.: ACE2 expression and activity are enhanced during pregnancy. Am. J. Physiol. Regul. Integr. Comp. Physiol., 295, R1953-R1961 (2008)CrossRefPubMedGoogle Scholar
  67. 67.
    Feng, Y.; Yue, X.; Xia, H.; Bindom, S.M.; Hickman, P.J.; Filipeanu, C.M.; Wu, G.; Lazartigues, E.: Angiotensin-converting enzyme 2 overexpression in the subfornical organ prevents the angiotensin II-mediated pressor and drinking responses and is associated with angiotensin II type 1 receptor downregulation. Circ. Res., 102, 729-736 (2008)CrossRefPubMedGoogle Scholar
  68. 68.
    Lai, Z.W.; Lew, R.A.; Yarski, M.A.; Mu, F.T.; Andrews, R.K.; Smith, A.I.: The identification of a calmodulin-binding domain within the cytoplasmic tail of angiotensin-converting enzyme-2. Endocrinology, 150, 2376-2381 (2009)CrossRefPubMedGoogle Scholar
  69. 69.
    Rushworth, C.A.; Guy, J.L.; Turner, A.J.: Residues affecting the chloride regulation and substrate selectivity of the angiotensin-converting enzymes (ACE and ACE2) identified by site-directed mutagenesis. FEBS J., 275, 6033-6042 (2008)CrossRefPubMedGoogle Scholar
  70. 70.
    Hernandez Prada, J.A.; Ferreira, A.J.; Katovich, M.J.; Shenoy, V.; Qi, Y.; Santos, R.A.; Castellano, R.K.; Lampkins, A.J.; Gubala, V.; Ostrov, D.A.; Raizada, M.K.: Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents. Hypertension, 51, 1312-1317 (2008)CrossRefPubMedGoogle Scholar
  71. 71.
    Huang, Q.; Xie, Q.; Shi, C.C.; Xiang, X.G.; Lin, L.Y.; Gong, B.D.; Zhao, G.D.; Wang, H.; Jia, NN.: Expression of angiotensin-converting enzyme 2 in CCL4-induced rat liver fibrosis. Int. J. Mol. Med., 23, 717-723 (2009)PubMedGoogle Scholar
  72. 72.
    Towler, P.; Staker, B.; Prasad, S.G.; Menon, S.; Tang, J.; Parsons,T.; Ryan, D.; Fisher, M.; Williams, D.; Dales, N.A.; Patane, M.A.; Pantoliano, M.W.: ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis. J. Biol. Chem., 279, 17996-18007 (2004)CrossRefPubMedGoogle Scholar
  73. 73.
    Ferreira. A.J.; Raizada, M.K.: Are we poised to target ACE2 for the next generation of antihypertensives?. J. Mol. Med., 86, 685-690 (2008)CrossRefGoogle Scholar
  74. 74.
    Xia, H.; Lazartigues, E.: Angiotensin-converting enzyme 2 in the brain: properties and future directions. J. Neurochem., 107, 1482-1494 (2008)CrossRefPubMedGoogle Scholar
  75. 75.
    Luhtala, S.; Vaajanen, A.; Oksala, O.; Valjakka, J.; Vapaatalo, H.: Activities of angiotensin-converting enzymes ACE1 and ACE2 and inhibition by bioactive peptides in porcine ocular tissues. J. Ocul. Pharmacol. Ther., 25, 23-28 (2009)CrossRefPubMedGoogle Scholar
  76. 76.
    Sluimer, J.C.; Gasc, J.M.; Hamming, I.; van Goor, H.; Michaud, A.; van den Akker, L.H.; Juetten, B.; Cleutjens, J.; Bijnens, A.P.; Corvol, P.; Daemen, M.J.; Heeneman, S.: Angiotensin-converting enzyme 2 (ACE2) expression and activity in human carotid atherosclerotic lesions. J. Pathol., 215, 273-279 (2008)CrossRefPubMedGoogle Scholar
  77. 77.
    Bindom, S.M.; Lazartigues, E.: The sweeter side of ACE2: physiological evidence for a role in diabetes. Mol. Cell. Endocrinol., 302, 193-202 (2009)CrossRefPubMedGoogle Scholar
  78. 78.
    Oudit, G.Y.; Imai, Y.; Kuba, K.; Scholey, J.W.; Penninger, J.M.: The role of ACE2 in pulmonary diseases - relevance for the nephrologist.. Nephrol. Dial. Transplant., 24, 1362-1365 (2009)CrossRefPubMedGoogle Scholar
  79. 79.
    Vaz-Silva, J.; Carneiro, M.M.; Ferreira, M.C.; Pinheiro, S.V.; Silva, D.A.; Silva-Filho, A.L.; Witz, C.A.; Reis, A.M.; Santos, R.A.; Reis, F.M.: The vasoactive peptide angiotensin-(1-7), its receptor Mas and the angiotensin-converting enzyme type 2 are expressed in the human endometrium. Reprod. Sci., 16, 247-256 (2009)CrossRefPubMedGoogle Scholar
  80. 80.
    Zhou, L.; Zhang, R.; Yao, W.; Wang, J.; Qian, A.; Qiao, M.; Zhang, Y.; Yuan, Y.: Decreased expression of Angiotensin-converting enzyme 2 in pancreatic ductal adenocarcinoma is associated with tumor progression. Tohoku J. Exp. Med., 217, 123-131 (2009)CrossRefPubMedGoogle Scholar
  81. 81.
    Clayton, D.; Hanchapola, I.; Perlmutter, P.; Smith, A.I.; Aguilar, M.I.: The active site specificity of angiotensin II converting enzyme 2 investigated through single and multiple residue changes and β-amino acid substrate analogs. Adv. Exp. Med. Biol., 611, 559-560 (2009)CrossRefPubMedGoogle Scholar
  82. 82.
    Trask, A.J.; Groban, L.; Westwood, B.M.; Varagic, J.; Ganten, D.; Gallagher, P.E.; Chappell, M.C.; Ferrario, C.M.: Inhibition of angiotensin-converting enzyme 2 exacerbates cardiac hypertrophy and fibrosis in Ren-2 hypertensive rats. Am. J. Hypertens., 23, 687-693 (2010)CrossRefPubMedGoogle Scholar
  83. 83.
    Iwata, M.; Silva Enciso, J.E.; Greenberg, B.H.: Selective and specific regulation of ectodomain shedding of angiotensin-converting enzyme 2 by tumor necrosis factor α-converting enzyme. Am. J. Physiol. Cell Physiol., 297, C1318-C1329 (2009)CrossRefPubMedGoogle Scholar
  84. 84.
    Jia, H.P.; Look, D.C.; Tan, P.; Shi, L.; Hickey, M.; Gakhar, L.; Chappell, M.C.; Wohlford-Lenane, C.; McCray, P.B.: Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia. Am. J. Physiol. Lung Cell Mol. Physiol., 297, L84-L96 (2009)CrossRefPubMedGoogle Scholar
  85. 85.
    Takahashi, Y.; Haga, S.; Ishizaka, Y.; Mimori, A.: Autoantibodies to angiotensin-converting enzyme 2 in patients with connective tissue diseases. Arthritis Res. Ther., 12, R85 (2010)CrossRefPubMedGoogle Scholar
  86. 86.
    Kassiri, Z.; Zhong, J.; Guo, D.; Basu, R.; Wang, X.; Liu, P.P.; Scholey, J.W.; Penninger, J.M.; Oudit, G.Y.: Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction. Circ. Heart Fail., 2, 446-455 (2009)CrossRefPubMedGoogle Scholar
  87. 87.
    Huang, M.L.; Li, X.; Meng, Y.; Xiao, B.; Ma, Q.; Ying, S.S.; Wu, P.S.; Zhang, Z.S.: Upregulation of angiotensin-converting enzyme (ACE) 2 in hepatic fibrosis by ACE inhibitors. Clin. Exp. Pharmacol. Physiol., 37, e1-e6 (2010)CrossRefPubMedGoogle Scholar
  88. 88.
    Zhao, Y.; Yin, H.Q.; Yu, Q.T.; Qiao, Y.; Dai, H.Y.; Zhang, M.X.; Zhang, L.; Liu, Y.F.; Wang, L.C.; Liu, D.S.; Deng, B.P.; Zhang, Y.H.; Pang, C.M.; Song, H.D.; Qu, X.; Jiang, H.; Liu, C.X.; Lu, X.T.; Liu, B.; Gao, F.; Dong, B.: ACE2 overexpression improves left ventricular remodeling and function in rats with myocardial infarction. Hum. Gene Ther., 21, 1545-1554 (2010)CrossRefPubMedGoogle Scholar
  89. 89.
    Xia, H.; Feng, Y.; Obr, T.D.; Hickman, P.J.; Lazartigues, E.: Angiotensin II type 1 receptor-mediated reduction of angiotensin-converting enzyme 2 activity in the brain impairs baroreflex function in hypertensive mice. Hypertension, 53, 210-216 (2009)CrossRefPubMedGoogle Scholar
  90. 90.
    Masson, R.; Nicklin, S.A.; Craig, M.A.; McBride, M.; Gilday, K.; Gregorevic, P.; Allen, J.M.; Chamberlain, J.S.; Smith, G.; Graham, D.; Dominiczak, A.F.; Napoli, C.; Baker, A.H.: Onset of experimental severe cardiac fibrosis is mediated by overexpression of angiotensin-converting enzyme 2. Hypertension, 53, 694-700 (2009)CrossRefPubMedGoogle Scholar
  91. 91.
    Stewart, J.M.; Ocon, A.J.; Clarke, D.; Taneja, I.; Medow, M.S.: Defects in cutaneous angiotensin-converting enzyme 2 and angiotensin-(1-7) production in postural tachycardia syndrome. Hypertension, 53, 767-774 (2009)CrossRefPubMedGoogle Scholar
  92. 92.
    Yoshikawa, N.; Yoshikawa, T.; Hill, T.; Huang, C.; Watts, D.M.; Makino, S.; Milligan, G.; Chan, T.; Peters, C.J.; Tseng, C.T.: Differential virological and immunological outcome of severe acute respiratory syndrome coronavirus infection in susceptible and resistant transgenic mice expressing human angiotensin-converting enzyme 2. J. Virol., 83, 5451-5465 (2009)CrossRefPubMedGoogle Scholar
  93. 93.
    Fraga-Silva, R.A.; Sorg, B.S.; Wankhede, M.; Dedeugd, C.; Jun, J.Y.; Baker, M.B.; Li, Y.; Castellano, R.K.; Katovich, M.J.; Raizada, M.K.; Ferreira, A.J.: ACE2 activation promotes antithrombotic activity. Mol. Med., 16, 210-215 (2010)CrossRefPubMedGoogle Scholar
  94. 94.
    Feng, Y.; Wan, H.; Liu, J.; Zhang, R.; Ma, Q.; Han, B.; Xiang, Y.; Che, J.; Cao, H.; Fei, X.; Qiu, W.: The angiotensin-converting enzyme 2 in tumor growth and tumor-associated angiogenesis in non-small cell lung cancer. Oncol. Rep., 23, 941-948 (2010)PubMedGoogle Scholar
  95. 95.
    Lin, C.S.; Pan, C.H.; Wen, C.H.; Yang, T.H.; Kuan, T.C.: Regulation of angiotensin converting enzyme II by angiotensin peptides in human cardiofibroblasts. Peptides, 31, 1334-1340 (2010)CrossRefPubMedGoogle Scholar
  96. 96.
    Coelho, M.S.; Lopes, K.L.; Freitas, R.d.e.A.; de Oliveira-Sales, E.B.; Bergasmaschi, C.T.; Campos, R.R.; Casarini, D.E.; Carmona, A.K.; Araujo, M.d.a..S.; Heimann, J.C.; Dolnikoff, M.S.: High sucrose intake in rats is associated with increased ACE2 and angiotensin-(1-7) levels in the adipose tissue. Regul. Pept., 162, 61-67 (2010)Google Scholar
  97. 97.
    Han, S.X.; He, G.M.; Wang, T.; Chen, L.; Ning, Y.Y.; Luo, F.; An, J.; Yang, T.; Dong, J.J.; Liao, Z.L.; Xu, D.; Wen, F.Q.: Losartan attenuates chronic cigarette smoke exposure-induced pulmonary arterial hypertension in rats: possible involvement of angiotensin-converting enzyme-2. Toxicol. Appl. Pharmacol., 245, 100-107 (2010)CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  1. 1.Bioinformatics & Systems BiologyTechnical University BraunschweigBraunschweigGermany

Personalised recommendations